Heiner C. Bucher
Basel Institute for Clinical Epidemiology & Biostatistics
Basel
Switzerland
Name/email consistency: high
- Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy. Bucher, H.C., Rickenbach, M., Young, J., Glass, T.R., Vallet, Y., Bernasconi, E., Cavassini, M., Fux, C., Schiffer, V., Vernazza, P., Weber, R., Battegay, M. Antivir. Ther. (Lond.) (2010)
- Protease inhibitor-sparing simplified maintenance therapy: a need for perspective. Bucher, H.C., Young, J., Battegay, M. J. Antimicrob. Chemother. (2004)
- Effect of amoxicillin-clavulanate in clinically diagnosed acute rhinosinusitis: a placebo-controlled, double-blind, randomized trial in general practice. Bucher, H.C., Tschudi, P., Young, J., Périat, P., Welge-Lüussen, A., Züst, H., Schindler, C. Arch. Intern. Med. (2003)
- Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients: the Swiss HIV Cohort Study. Bucher, H.C., Bichsel, M., Taffé, P., Furrer, H., Telenti, A., Hirschel, B., Weber, R., Bernasconi, E., Vernazza, P., Minder, C., Battegay, M. HIV Med. (2002)
- Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials. Bucher, H.C., Hengstler, P., Schindler, C., Guyatt, G.H. BMJ (2000)